Are you ready to delve into the forefront of AAV-mediated gene therapy development? Look no further!
Discover how integrating immuno- and cell-based methods meets the critical need in AAV-mediated gene therapy development by accurately assessing NAbs and TAbs in our new scientific posters. You will also gain insights into predictive immunogenicity assessment and the importance of comprehensive patient response evaluation.
Download our scientific posters today and unlock a wealth of insights into AAV-mediated gene therapy development. Simply fill out the form below to access the download links.
Comprehensive Immunogenicity Analysis of AAV Therapies:
Correlating Anti-AAV Antibodies (NAbs/TAbs) with Complement Activation Dynamics
Celik S, Kulak K, Kozma V, Klint C, Vallette B, Nilsson C, Lallemand C, Tovey M, Bovin L F, Butler S, Schwenkert M, Rodo J
Learn more about how combining immuno- and cell-based methodologies, effectively addresses the crucial demand in the clinical development of AAV-mediated gene therapies by providing precise assessments of NAbs and TAbs.
Elucidating Complement Activation Mechanisms In AAV Gene Therapy: Development of a Novel ELISA-Based Assay for Enhanced Safety and Efficacy
Kulak K, Kozma V, Klint C, Nilsson C , Butler S, Schwenkert M, Rodo J
Gain deeper insights into the predictive assessment of AAV-mediated immunogenicity and how understanding and evaluating patient responses to AAV-mediated gene therapy comprehensively is crucial.
